The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ACADIA Pharmaceuticals Inc(NASDAQ:ACAD) 
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associ...
Website: http://www.acadia-pharm.com
Founded: 1993
Full Time Employees: 580
CEO: Catherine Owen Adams
Sector: Healthcare
Industry: Biotechnology
ACADIA Pharmaceuticals Days Payable Outstanding ttm (DPO)
ACADIA Pharmaceuticals Days Receivable Outstanding ttm (DSO)
ACADIA Pharmaceuticals Days Inventory Outstanding ttm (DIO)
ACADIA Pharmaceuticals Op Cashflow Per Share ttm
ACADIA Pharmaceuticals Free Cashflow Per Share ttm
ACADIA Pharmaceuticals Cash Per Share ttm
ACADIA Pharmaceuticals P/S ratio ttm
ACADIA Pharmaceuticals (GAAP) P/E ratio ttm
ACADIA Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.